We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-0.66%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$694M
AUM Growth
-$235M
(-25%)
Cap. Flow
-$209M
Cap. Flow
% of AUM
-30.05%
Top 10 Holdings %
Top 10 Hldgs %
4.41%
Holding
1,236
New
502
Increased
176
Reduced
298
Closed
257
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$2.36M |
| 2 |
Collegium Pharmaceutical
COLL
|
+$2.32M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.29M |
| 4 |
HSII
Heidrick & Struggles
HSII
|
+$2.25M |
| 5 |
HTCH
HUTCHINSON TECHNOLOGY INC
HTCH
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emergent Biosolutions
EBS
|
+$5.99M |
| 2 |
Commercial Metals
CMC
|
+$5.95M |
| 3 |
Benchmark Electronics
BHE
|
+$5.84M |
| 4 |
Upbound Group
UPBD
|
+$5.71M |
| 5 |
FreightCar America
RAIL
|
+$5.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.04% |
| 2 | Industrials | 15.17% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Financials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GCI
126
DELISTED
Gannett Co., Inc
GCI
| $1.54M | 0.22% |
+101,853
| New | +$1.54M |
|
127
Murphy USA
MUSA
$11.3B
| $1.54M | 0.22% |
25,053
-29,002
| -54% | -$1.78M |
|
128
HNI Corp
HNI
$3B
| $1.53M | 0.22% |
+39,115
| New | +$1.33M |
|
129
Green Plains
GPRE
$1.19B
| $1.52M | 0.22% |
+95,302
| New | +$1.53M |
|
|
LXK
130
DELISTED
Lexmark Intl Inc
LXK
| $1.52M | 0.22% |
+45,454
| New | +$1.34M |
|
131
SPS Commerce
SPSC
$2.25B
| $1.51M | 0.22% |
70,458
+14,880
| +27% | +$373K |
|
132
Avanos Medical
AVNS
$1.17B
| $1.51M | 0.22% |
52,597
-16,885
| -24% | -$450K |
|
133
Brookdale Senior Living
BKD
$3.62B
| $1.51M | 0.22% |
+95,122
| New | +$1.45M |
|
|
HEES
134
DELISTED
H&E Equipment Services
HEES
| $1.51M | 0.22% |
86,196
+73,622
| +586% | +$1.07M |
|
|
SVU
135
DELISTED
SUPERVALU Inc.
SVU
| $1.51M | 0.22% |
37,488
-83,530
| -69% | -$2.97M |
|
|
KTWO
136
DELISTED
K2M Group Holdings, Inc
KTWO
| $1.51M | 0.22% |
101,682
+66,018
| +185% | +$907K |
|
|
PHIIK
137
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
| $1.5M | 0.22% |
79,611
-37,915
| -32% | -$667K |
|
138
Park-Ohio Holdings
PKOH
$554M
| $1.49M | 0.22% |
+34,868
| New | +$1.1M |
|
139
Vince Holding Corp
VNCE
$76.2M
| $1.49M | 0.21% |
23,492
+21,207
| +928% | +$1.19M |
|
140
Century Casinos
CNTY
$32.9M
| $1.49M | 0.21% |
241,271
+160,937
| +200% | +$1.07M |
|
141
AZZ Inc
AZZ
$4.5B
| $1.48M | 0.21% |
+26,170
| New | +$1.36M |
|
142
UNIFI
UFI
$117M
| $1.48M | 0.21% |
64,627
+30,536
| +90% | +$725K |
|
|
RNET
143
DELISTED
RigNet, Inc.
RNET
| $1.47M | 0.21% |
+107,247
| New | +$1.48M |
|
|
CIVI
144
DELISTED
Civitas Solutions, Inc.
CIVI
| $1.47M | 0.21% |
84,161
+6,893
| +9% | +$142K |
|
|
ZEUS
145
DELISTED
Olympic Steel
ZEUS
| $1.47M | 0.21% |
84,718
-116,918
| -58% | -$1.39M |
|
146
LeMaitre Vascular
LMAT
$2.18B
| $1.46M | 0.21% |
93,800
-82,537
| -47% | -$1.18M |
|
147
Globus Medical
GMED
$10.4B
| $1.45M | 0.21% |
+61,057
| New | +$1.49M |
|
148
Great Southern Bancorp
GSBC
$863M
| $1.45M | 0.21% |
+38,936
| New | +$1.51M |
|
|
AXLL
149
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $1.42M | 0.2% |
64,942
-94,147
| -59% | -$1.66M |
|
150
Photronics
PLAB
$1.79B
| $1.42M | 0.2% |
136,135
-94,693
| -41% | -$1.02M |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q1 2016 Portfolio in Review
As of Q1 2016, TFS Capital held 1,236 positions worth $694M, down 25% from $929M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
TFS Capital withdrew a net $209M in Q1 2016, closing 257 positions and reducing 298 holdings. Its most notable exit was Benchmark Electronics, an estimated $5.84M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.
Against the trend, TFS Capital opened a new position in Collegium Pharmaceutical worth $2.31M.
- TFS Capital's largest Q1 2016 buy was Collegium Pharmaceutical: 127,568 shares worth $2.31M.
- TFS Capital added most to Infinity Pharmaceuticals, Inc. in Q1 2016, an estimated $2.36M increase.
- TFS Capital's biggest Q1 2016 reduction was Emergent Biosolutions, cutting an estimated $5.99M.
- TFS Capital fully exited Benchmark Electronics in Q1 2016, selling an estimated $5.84M.
- TFS Capital's ten largest holdings make up 4.4% of its $694M portfolio in Q1 2016.
- TFS Capital opened 502 new positions and closed 257 in Q1 2016.
- TFS Capital's portfolio value fell 25% quarter-over-quarter to $694M.
Based on TFS Capital's 13F filing for Q1 2016, filed 10 May 2016.